A unique subtype of diffuse large B-cell lymphoma primarily involving the bone marrow, spleen, and liver, defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography

References

• Stein H, Chan JKC, Warnke RA, et al. Diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 233–237.
   Google Scholar
• Morice WG, Rodriguez FJ, Hoyer JD, et al. Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases. Mod Pathol. 2005;18:495–502.
   PubMed Web of Science ®Google Scholar
• Yeh YM, Chang KC, Chen YP, et al. Large B cell lymphoma presenting initially in bone marrow, liver and spleen: an aggressive entity associated frequently with haemophagocytic syndrome. Histopathology. 2010;57:785–795.
   PubMed Web of Science ®Google Scholar
• Kajiura D, Yamashita Y, Mori N. Diffuse large B-cell lymphoma initially manifesting in the bone marrow. Am J Clin Pathol. 2007;127:762–769.
   PubMed Web of Science ®Google Scholar
• Martinez A, Ponzoni M, Agostinelli C, et al. Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-hodgkin lymphomas. Am J Surg Pathol. 2012;36:296–304.
   PubMed Web of Science ®Google Scholar
• Alvares CL, Matutes E, Scully MA, et al. Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma. 2004;45:769–775.
   PubMed Web of Science ®Google Scholar
• Chang H, Hung YS, Lin TL, et al. Primary bone marrow diffuse large B cell lymphoma: a case series and review. Ann Hematol. 2011;90:791–796.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068.
   PubMed Web of Science ®Google Scholar
• Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol. 2011;29:1844–1854.
   PubMed Web of Science ®Google Scholar
• Arber DA, George TI. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005;29:1549–1557.
   PubMed Web of Science ®Google Scholar
• ISCN (2013). In: Schaffer LG, McGowan-Jordan J, Schmid M, editors. An international system for human cytogenetic nomenclature. Basel: S. Karger; 2013.
   Google Scholar
• Yasuda M, Iioka F, Kamoda Y, et al. CD5-positive diffuse large B-cell lymphoma showing prominent intra-sinusoidal infiltration in the bone marrow, successfully treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone in combination with rituximab. Tenri Med Bull. 2013;16:31–39.
   Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282.
   PubMed Web of Science ®Google Scholar
• Khan AB, Barrington SF, Mikhaeel NG, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood. 2013;122:61–67.
   PubMed Web of Science ®Google Scholar
• Sovani V, Harvey C, Haynes AP, et al. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings. J Clin Pathol. 2014;67:389–395.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Ponzoni M, Campo E. Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 252–253.
   Google Scholar
• Shimada K, Kinoshita T, Naoe T, et al. Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol. 2009;10:895–902.
   PubMed Web of Science ®Google Scholar
• Ponzoni M, Ferreri AJ, Campo E, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007;25:3168–3173.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Dognini GP, Campo E, et al. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica. 2007;92:486–492.
   PubMed Web of Science ®Google Scholar
• Colavolpe C, Ebbo M, Trousse D, et al. FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature. Hematol Oncol. 2015;33:99–109.
   PubMed Web of Science ®Google Scholar
• Miura Y, Tsudo M. Fluorodeoxyglucose-PET/CT for diagnosis of intravascular large B-cell lymphoma. Mayo Clin Proc. 2010;85:e56–e57.
   Google Scholar
• Ohno H. Pathogenetic and clinical implications of non-immunoglobulin ; BCL6 translocations in B-cell non-Hodgkin's lymphoma. J Clin Exp Hematop. 2006;46:43–53.
   PubMedGoogle Scholar
• Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood. 2003;102:1443–1448.
   PubMed Web of Science ®Google Scholar
• Montesinos-Rongen M, Akasaka T, Zuhlke-Jenisch R, et al. Molecular characterization of BCL6 breakpoints in primary diffuse large B-cell lymphomas of the central nervous system identifies GAPD as novel translocation partner. Brain Pathol. 2003;13:534–538.
   PubMed Web of Science ®Google Scholar
• Berglund M, Enblad G, Flordal E, et al. Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol. 2002;15:807–816.
   PubMed Web of Science ®Google Scholar
• Tagawa H, Suguro M, Tsuzuki S, et al. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood. 2005;106:1770–1777.
   PubMed Web of Science ®Google Scholar
• Monni O, Joensuu H, Franssila K, et al. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood. 1997;90:1168–1174.
   PubMed Web of Science ®Google Scholar
• Karube K, Ying G, Tagawa H, et al. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol. 2008;21:973–978.
   PubMed Web of Science ®Google Scholar
• Stasik CJ, Nitta H, Zhang W, et al. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica. 2010;95:597–603.
   PubMed Web of Science ®Google Scholar
• Hishizawa M, Okamoto K, Chonabayashi K, et al. Primary large B-cell lymphoma of the bone marrow. Br J Haematol. 2007;136:351.
   PubMedGoogle Scholar